Vibegron
Back to searchMolecule Structure
Scientific Name
Vibegron
Description of the Drug
Vibegron is a beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14895
http://www.drugbank.ca/drugs/DB14895
Brand Name(s)
Gemtesa
Company Owner(s)
Urovant Sciences Gmbh
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-3 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL246 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL11985457 |
DrugBank | DB14895 |
PubChem: Thomson Pharma | 85752560 |
PubChem | 44472635 |
Nikkaji | J3.484.439I |
BindingDB | 50146154 |
EPA CompTox Dashboard | DTXSID40152299 |
DrugCentral | 5311 |
ChemicalBook | CB13159928 |
Guide to Pharmacology | 10100 |
ChEBI | 142418 |
ZINC | ZINC000084757336 |